Trial
NCT01288937
A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
Forest Laboratories
Condition
Idiopathic Peripheral Neuropathy
Intervention
Milnacipran
Why stopped
Poor recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-03